Loncar China BioPharma ETF (CHNA) 은(는) 상장 기업입니다 금융 섹터의 Asset Management 산업에서 운영.
CHNA 을(를) 보유 IPO 날짜 2018-08-15, 에 상장 NASDAQ Global Market.
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
